Concepedia

Chenfei Chi

CC

21

Publications

648

Citations

15

H-Index

2017

Active since

Affiliations

Renji Hospital(Current)

Shanghai Jiao Tong University

Shanghai Institute of Hematology

Shanghai Sixth People's Hospital

Chenfei Chi is an author at Renji Hospital specializing in health sciences, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2017–2024

21

Publications

21

Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients

Liancheng Fan, Rui Wang, Chenfei Chi et al. · The Prostate · 2017 · 61 citations

PRKAR2B promotes prostate cancer metastasis by activating Wnt/β‐catenin and inducing epithelial‐mesenchymal transition

Jianjun Sha, Qing Han, Chenfei Chi et al. · Journal of Cellular Biochemistry · 2018 · 57 citations

PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer

Lei Xia, Jian Sun, Shaowei Xie et al. · Cell Proliferation · 2020 · 56 citations · Full text

Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer

Lei Xia, Qing Han, Chenfei Chi et al. · Biomedicine & Pharmacotherapy · 2020 · 55 citations · Full text

Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone

Liancheng Fan, Xiao Wang, Chenfei Chi et al. · The Prostate · 2017 · 40 citations

Rows per page

1–5 of 21